Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is one of the highest fatality rate cancers with poor survival rates. The tumor microenvironment (TME) is vital for tumor immune responses, leading to resistance to chemotherapy and poor prognosis of PDAC patients. This study aimed to provide a compre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Wang, Weijia, Yan, Liang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Tian, Xiuyun, Hao, Chunyi
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945593/
https://ncbi.nlm.nih.gov/pubmed/33718118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.618215
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky